![]() Solvotrin Therapeutics Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 2009 | Founding Date 1985 | Founding Date 1907 | Founding Date 1964 | Founding Date 1928 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations IE HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations BR HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 21 | Employees 8,933 | Employees 14,8582% increase | Employees 12,2145% decrease | Employees 9,000 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥12.2b (FY, 2023) | Revenue (est.) ₹61.1b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) €4.9b (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.5b (FY, 2023) | Cost of goods ₹19.3b (FY, 2024) | Cost of goods N/A | Cost of goods €1b (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit ¥7.8b (FY, 2023) | Gross profit ₹43b (FY, 2024) | Gross profit N/A | Gross profit €4.8b (FY, 2023) |
Net income | Net income N/A | Net income ¥1.9b (FY, 2023) | Net income ₹6.2b (FY, 2024) | Net income N/A | Net income €343m (FY, 2023) |
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyAlembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View companyEMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View companyUCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company